GlaxoSmithKline News and Research

RSS

Vaccinating both boys and girls can help eliminate HPV infections

The human papillomavirus causes, amongst other diseases, cancer of the cervix and oropharynx. A Swedish-Finnish study published in The Journal of Infectious Diseases now shows that the most oncogenic HPV types can be eliminated, but only if both girls and boys are vaccinated.

12 Mar 2020

Investigating the nanoscale adhesion mechanisms between polymeric biomaterials and biological samples

Queen Mary University of London and GSK demonstrate the complex nature of nanoscale adhesion mechanisms between polymeric biomaterials and biological samples.

From Henniker Plasma 9 Mar 2020

APEIRON Biologics launches clinical trial of respiratory drug to treat coronavirus infection

APEIRON Biologics AG, a biotechnology company with an approved product on the market as well as a broad preclinical and clinical pipeline, today announced the launch of a Pilot investigator-initiated clinical trial with APN01, a recombinant human angiotensin-converting enzyme 2, to treat patients with severe coronavirus infection in the People's Republic of China.

26 Feb 2020

Genome research collaboration in Finland welcomes Janssen and Maze Therapeutics

FinnGen, a large-scale academic - industry, genome research collaboration in Finland now includes eleven industry partners with the addition of the Janssen Pharmaceutical Companies of Johnson & Johnson and Maze Therapeutics.

25 Feb 2020

CQDM and GlycoNet collaborate to support innovative glycomics research in Canada

CQDM and the Canadian Glycomics Network (GlycoNet) are pleased to announce they have formed a strategic partnership to identify and co-finance biopharmaceutical research projects in glycoscience across Canada.

25 Feb 2020

Scientists report promising activity of novel targeted drug in patients with advanced kidney cancer

Scientists report promising activity of a novel drug that targets a key molecular driver of clear cell renal cell carcinoma (ccRCC) in patients with metastatic disease.

13 Feb 2020

Recent progress in TB diagnostics and prevention approaches offers hope for future

In September 2018, the National Institute of Allergy and Infectious Diseases, part of the NIH, issued its Strategic Plan for Tuberculosis Research, which outlined research priorities to reduce and ultimately end the burden of tuberculosis.

11 Feb 2020

New study confirms link between type 2 diabetes drug and increased risk of heart problems

A new study published by The BMJ adds to evidence that rosiglitazone - a drug used to treat type 2 diabetes - is associated with increased risk of heart problems, especially heart failure.

11 Feb 2020

ERA4TB to transform the development of new therapies for tuberculosis

With a team of more than thirty public and private organisations and a budget over 200 million euro, ERA4TB aims to radically transform the way in which new therapies are developed for the treatment of tuberculosis.

30 Jan 2020

An old plant virus inspires the design of novel second-generation malaria vaccine

Scientists from the Walter Reed Army Institute of Research have demonstrated that a novel, second-generation malaria vaccine candidate based on the tobacco mosaic virus may offer protection against Plasmodium falciparum malaria in the upcoming issue of the journal Proceedings of the National Academy of Sciences.

27 Jan 2020

Study findings have implications for meningococcal B vaccine programs globally

The results of the B Part of It study – the largest meningococcal B herd immunity study ever conducted – are published today in the New England Journal of Medicine.

22 Jan 2020

UTHSC College of Pharmacy, Kroger Health partner to improve shingles vaccination completion rates

The College of Pharmacy at the University of Tennessee Health Science Center has partnered with Kroger Health, the healthcare arm of The Kroger Co., on a nationwide, randomized controlled study across more than 2,200 community pharmacy locations to improve second-dose vaccination completion rates for the shingles vaccine. Elements of the project are funded through a grant from GlaxoSmithKline.

22 Jan 2020

GlaxoSmithKline News and Research

Vaccinating both boys and girls can help eliminate HPV infections

Investigating the nanoscale adhesion mechanisms between polymeric biomaterials and biological samples

APEIRON Biologics launches clinical trial of respiratory drug to treat coronavirus infection

Genome research collaboration in Finland welcomes Janssen and Maze Therapeutics

CQDM and GlycoNet collaborate to support innovative glycomics research in Canada

Scientists report promising activity of novel targeted drug in patients with advanced kidney cancer

Recent progress in TB diagnostics and prevention approaches offers hope for future

New study confirms link between type 2 diabetes drug and increased risk of heart problems

ERA4TB to transform the development of new therapies for tuberculosis

An old plant virus inspires the design of novel second-generation malaria vaccine

Study findings have implications for meningococcal B vaccine programs globally

UTHSC College of Pharmacy, Kroger Health partner to improve shingles vaccination completion rates

Exposure to ozone pollution or wood smoke exacerbates lung disease in former and current smokers

Novel 'tooth-on-a-chip' could open door to personalized dental care

New combination therapy can lead to durable responses in patients with multiple myeloma

Newly identified antibody has potential to stop, reverse pulmonary arterial hypertension

Retinal hyperspectral imaging shows promise for early Alzheimer's disease detection

Study identifies a kinase as potential target to treat heart failure

New TB vaccine: mid-phase trials confirm safety, long-term prevention

Novel approach brings researchers one step closer to universal flu vaccine

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News